What did @abbyg.garcia actually say?
She didn't make sweeping medical claims. This is a week-two injection diary, not a wellness lecture. She described drawing up her dose, flipping the vial, pushing out air bubbles, and slowly pulling out the needle after injecting. She also mentioned being "terrified of needles" and admitted her heart pounds after each shot. The main technical claim worth scrutinizing is her specific syringe technique: draw to 25 units, flip, push air bubbles in, return to 25, flip again, then inject.
That reconstruction-from-vial process suggests she is using a multi-dose vial format, likely a compounded semaglutide product, rather than the prefilled auto-injector pen used for Ozempic or Wegovy. That distinction matters more than most viewers probably realize, and it is worth unpacking carefully.
Does the science back this up?
The injection site rotation she describes, alternating sides of the abdomen each week, is textbook correct. Clinical guidance for subcutaneous GLP-1 agonist administration consistently recommends rotating sites to reduce lipohypertrophy, the lumpy fat buildup that can reduce drug absorption.
Rotation between the abdomen, thigh, and upper arm is recommended by the American Diabetes Association and supported by pharmacokinetic data showing that absorption rates can differ meaningfully by site (Frid et al., 2016, Diabetes Technology and Therapeutics). Abdominal injection generally produces the most consistent absorption profile for subcutaneous drugs, so her choice of site is reasonable.
The air bubble technique she describes, drawing slightly past the target volume and then expelling air before re-drawing to the correct volume, is a standard reconstitution practice used in clinical settings. It is not dangerous when done correctly, but it does require more precision than a prefilled pen, where dose calibration is handled mechanically.
What did they get wrong (or right)?
She got the site rotation right. She got the "go slow on the withdrawal" approach right. Rapid needle removal can drag medication back out of the subcutaneous tissue, so pulling out slowly after injection is actually the better technique, though instructions vary by device.
What she got ambiguous is the overall setup. Her vial-and-syringe method strongly implies a compounded semaglutide product. Compounded semaglutide is not FDA-approved and is not equivalent to brand-name Ozempic or Wegovy. The FDA issued warnings in 2023 and 2024 about compounded semaglutide products, citing dosing errors and contamination risks, particularly with products containing semaglutide sodium or acetate salt rather than the base form used in approved drugs (FDA Drug Safety Communication, 2024).
She does not tell viewers what product she is using, what dose she is taking, or whether she is under clinical supervision. At 801,000 views, that omission is not trivial. Viewers with PCOS seeing this may interpret it as a tutorial for self-administering any semaglutide product they can source, which is a real safety concern.
What should you actually know?
Semaglutide is not FDA-approved specifically for PCOS, but off-label use is clinically documented. A 2023 randomized controlled trial by Cree-Green et al. in the Journal of Clinical Endocrinology and Metabolism found GLP-1 receptor agonist therapy improved insulin sensitivity and menstrual regularity in women with PCOS. The mechanism makes biological sense: PCOS is strongly linked to insulin resistance, and semaglutide reduces hepatic glucose output and improves insulin signaling.
That said, "it makes sense" is not the same as "it is approved for this use." Anyone using semaglutide for PCOS should be doing so under the supervision of a licensed provider who can monitor for side effects, confirm appropriate dosing, and rule out contraindications like a personal or family history of medullary thyroid carcinoma.
The injection technique shown here is not dangerous if performed correctly with a properly sourced, properly stored product under clinical guidance. But this video, taken alone, is not a tutorial anyone should follow without that clinical layer in place.
The bottom line
This is a personal experience video, not a medical tutorial, and it should be read as such. She is documenting her own journey, and she deserves credit for not overclaiming. She never says semaglutide cures PCOS or tells viewers what dose to use. But the 800,000 people watching this will not all have that context. The technique she shows is largely reasonable. The product category she appears to be using carries real regulatory and safety caveats that the video does not address. If you are considering semaglutide for PCOS, the right first call is to a provider, not a TikTok comment section.